Sentencia (Reseña) nº T-182/17 of Tribunal General de la Unión Europea, Sala 3ª, Tuesday September 25, 2018
| Resolution Date | Tuesday September 25, 2018 |
| Issuing Organization | Sala Tercera |
| Decision Number | T-182/17 |
Sentencia del Tribunal General (Sala Tercera) de 25 de septiembre de 2018 - Novartis/EUIPO - Chiesi Farmaceutici (AKANTO)
(Asunto T-182/17) [«Marca de la Unión Europea - Procedimiento de oposición - Solicitud de marca denominativa de la Unión AKANTO - Marca denominativa anterior de la Unión KANTOS - Motivo de denegación relativo - Riesgo de confusión - Artículo 8, apartado 1, letra b), del Reglamento (CE) n.º 207/2009 [actualmente artículo 8, apartado 1, letra b), del Reglamento (UE) 2017/1001]»
-
Marca de la Unión Europea - Definición y adquisición de la marca de la Unión - Motivos de denegación relativos - Oposición del titular de una marca anterior idéntica o similar registrada para productos o servicios idénticos o similares - Riesgo de confusión con la marca anterior - Criterios de apreciación
[Reglamento (CE) n.º 207/2009 del Consejo, art. 8, ap. 1,...
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeUnlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
